Adenosine modification may be preferred for reducing siRNA immune stimulation.

Area of Science:

• Immunology
• Molecular Biology
• RNA Therapeutics

Background:

• Short interfering RNAs (siRNAs) can trigger immune responses.
• Chemical modifications at the ribose 2 position, like methoxy or fluoro, are known to reduce this immune stimulation.
• Systematic evaluation of modification types, nucleotide preference, and strand bias is lacking.

Purpose of the Study:

• To systematically evaluate the impact of various 2 -modified siRNAs on immune stimulation.
• To identify specific modifications and nucleotide preferences that reduce cytokine induction without compromising gene silencing efficacy.
• To determine the optimal modification strategy for developing safer and more effective siRNA therapeutics.

Main Methods:

• Screening of several modified siRNAs using a human peripheral blood monocyte cytokine induction assay.
• Assessing cytokine induction levels in response to modified siRNAs.
• Evaluating the gene knockdown activity of modified siRNAs.

Main Results:

• 2 -fluoro modification of adenosine significantly reduced cytokine induction.
• This reduction in immune stimulation was observed while retaining siRNA gene knockdown activity.
• Modifications of guanosine, cytidine, or uridine did not show the same combined effect of reduced immune stimulation and maintained knockdown.

Conclusions:

• Adenosine is an optimal target for 2 -fluoro modification to mitigate siRNA-induced immune stimulation.
• This modification strategy offers a promising approach for developing next-generation siRNA therapeutics with improved safety profiles.
• Further research into nucleotide-specific modifications can enhance the design of potent and non-immunogenic siRNA molecules.